Nicole B. Day

Nicole B. Day

Auto-generated profile, based on publicly available information

Nicole B. Day

Department of Chemical and Biological Engineering University of Colorado Boulder Boulder CO 80303 USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 July 2023 in ACS Nano
Verified
Journal Article
Closed access
JLJin Gyun Lee
Jin Gyun Lee
RRRitu R. Raj
Ritu R. Raj
NDNicole B. Day
Nicole B. Day
WSWyatt Shields
Wyatt Shields

30 April 2021 in Acta Pharmaceutica Sinica B
Verified
Journal Article
Open access
NDNicole B. Day
Nicole B. Day
WWWilliam C. Wixson
William C. Wixson
WSWyatt Shields
Wyatt Shields
Immunotherapy is a rapidly developing area of cancer treatment due to its higher specificity and potential for greater efficacy than traditional therapies. Immune cell modulation through the administration of drugs, proteins, and cells can enhance antitumoral responses through pathways that may be otherwise inhibited in the presence of immunosuppressive tumors. Magnetic systems offer several advantages for improving the performance of immunotherapies, including increased spatiotemporal control over transport, release, and dosing of immunomodulatory drugs within the body, resulting in reduced off-target effects and improved efficacy. Compared to alternative methods for stimulating drug release such as light and pH, magnetic systems enable several distinct methods for programming immune responses. First, we discuss how magnetic hyperthermia can stimulate immune cells and trigger thermoresponsive drug release. Second, we summarize how magnetically targeted delivery of drug carriers can increase the accumulation of drugs in target sites. Third, we review how biomaterials can undergo magnetically driven structural changes to enable remote release of encapsulated drugs. Fourth, we describe the use of magnetic particles for targeted interactions with cellular receptors for promoting antitumor activity. Finally, we discuss translational considerations of these systems, such as toxicity, clinical compatibility, and future opportunities for improving cancer treatment.

14 April 2023 in Small
Verified
Journal Article
Closed access
JLJin Gyun Lee
Jin Gyun Lee
RRRitu R. Raj
Ritu R. Raj
CTCooper P. Thome
Cooper P. Thome
NDNicole B. Day
Nicole B. Day
PMPayton Martinez
Payton Martinez
WSWyatt Shields
Wyatt Shields

4 December 2023 in ACS Applied Bio Materials
Verified
Journal Article
Closed access
NDNicole B. Day
Nicole B. Day
COChristopher R. Orear
Christopher R. Orear
AVAmbar C. Velazquez-Albino
Ambar C. Velazquez-Albino
HGHayden J. Good
Hayden J. Good
AMAndrii Melnyk
Andrii Melnyk
WSWyatt Shields
Wyatt Shields

1 August 2022 in Acta Biomaterialia
Verified
Journal Article
Closed access
NDNicole B. Day
Nicole B. Day
RDRianne Dalhuisen
Rianne Dalhuisen
NLNichole E. Loomis
Nichole E. Loomis
SASarah G. Adzema
Sarah G. Adzema
Jai PrakashJai Prakash
Jai Prakash
WSWyatt Shields
Wyatt Shields

7 August 2025 in Advanced Healthcare Materials
Verified
Journal Article
Closed access
MKMatthew M. C. Kwan
Matthew M. C. Kwan
NDNicole B. Day
Nicole B. Day
IKIain Konigsberg
Iain Konigsberg
ETEvan Thoresen
Evan Thoresen
AHAbigail G. Harrell
Abigail G. Harrell
WSWyatt Shields
Wyatt Shields